Seirei Mikatabara General Hospital
In research, Seirei Mikatabara General Hospital stands highest in Medicine (#7,318 of 10,443 worldwide) and Health Sciences (#8,926 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 12.7× its share of world research.
- World rank, 2022–2025
- #23,937 of 28,054 · #24,150 all time
- Rank in Japan
- #788 of 1,070
- Research works
- 636 ▲ 21% vs 2013–17
- Citations
- 11k 16.9 per fractional work
- Top-10% rate
- 7.7% record average 16.5%
- Open access
- 48% world 28%
What is Seirei Mikatabara General Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,318 of 10,443 | 6.9% | 90 | #5855 | |
| Health SciencesDomain | #8,926 of 11,982 | 7.4% | 97 | #7637 |
Each strip is that field’s whole ranked pool, with the notch where Seirei Mikatabara General Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Seirei Mikatabara General Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 12.7× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 21.2 works13×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.
- Medicine 4.3×
- Health Professions 2.1×
- Psychology 1.1×
- Biochemistry, Genetics and Molecular Biology 0.6×
- Veterinary 0.6×
- Nursing 0.5×
- Neuroscience 0.5×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Dentistry 0.3×
- Economics, Econometrics and Finance 0.2×
- Physics and Astronomy 0.1×
- Immunology and Microbiology 0.1×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Engineering 0.0×
- Mathematics 0.0×
- Computer Science 0.0×
Who are the top researchers at Seirei Mikatabara General Hospital?
Ranked on the composite score, Tatsuya Morita, Takuya Watanabe and Eriko Suzuki lead among researchers whose main affiliation is Seirei Mikatabara General Hospital.
- 1 Tatsuya Morita Japan · #58,525 worldwide 356 citations · 102 works
- 2 Takuya Watanabe Japan · #117,263 worldwide 163 citations · 41 works
- 3 Eriko Suzuki Japan · #430,738 worldwide 58 citations · 28 works
- 4 Hiroshi Ogawa Japan · #621,370 worldwide 31 citations · 20 works
- 5 Ichiro Fujishima Japan · #629,207 worldwide 37 citations · 42 works
- 6 Nobuhisa Nakajima Japan · #683,835 worldwide 22 citations · 19 works
- 7 Hiroshi Niwa Japan · #693,623 worldwide 64 citations · 70 works
- 8 Isseki Maeda Japan · #758,839 worldwide 42 citations · 19 works
- 9 Hirofumi Fujita Japan · #807,632 worldwide 33 citations · 23 works
- 10 Masanori Mori Japan · #920,568 worldwide 56 citations · 51 works
Which keywords describe research at Seirei Mikatabara General Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Treatment, Palliative Care, Ethical Considerations, End-of-Life, Advance Care Planning, Family Perspectives, Chemotherapy and Diagnosis.
- Pain Management
- Treatment Guidelines
- Psychosocial Interventions
- Prognosis
- TGF-ß
- Cancer Survivorship
- Intensive Care Unit
- Echocardiography
- Rehabilitation
- Targeted Therapy
- Clinical Trials
- Health-related Quality of Life
- CT Screening
- Tumor Staging
- Management
- Diagnosis
- Family Perspectives
- Quality of Life
- Ethical Considerations
- Palliative Care
- Treatment
- Epidemiology
- End-of-Life
- Advance Care Planning
- Chemotherapy
- Radiotherapy
- Adjuvant Therapy
- Elderly Patients
- Lung Cancer
- Immunotherapy
- Fibrosis
- Interstitial Lung Disease
- Genetic Mutations
- Prognostic Factors
- Surgical Management
- Idiopathic Pulmonary Fibrosis
- Genetic Susceptibility
- Patient-Reported Outcomes
- Sedation
- Endovascular Repair
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Treatment9▲ 7.1×24 topics
- Palliative Care8▲ 48×4 topics
- Epidemiology8▲ 1.95×45 topics
- Ethical Considerations8▲ 22×6 topics
- End-of-Life8▲ 81×3 topics
- Quality of Life8▲ 4.9×18 topics
- Advance Care Planning7▲ 114×1 topic
- Family Perspectives7▲ 114×1 topic
- Chemotherapy7▲ 9.6×18 topics
- Diagnosis7▲ 6.9×17 topics
- Radiotherapy6▲ 14×11 topics
- Management5▲ 6.0×14 topics
- Adjuvant Therapy5▲ 34×2 topics
- Tumor Staging4▲ 37×2 topics
- Elderly Patients4▲ 23×3 topics
- CT Screening4▲ 57×1 topic
- Lung Cancer4▲ 22×1 topic
- Health-related Quality of Life4▲ 16×2 topics
- Immunotherapy4▲ 5.0×14 topics
- Clinical Trials4▲ 5.2×6 topics
- Fibrosis4▲ 18×3 topics
- Targeted Therapy4▲ 14×4 topics
- Interstitial Lung Disease3▲ 49×2 topics
- Rehabilitation3▲ 8.0×4 topics
- Genetic Mutations3▲ 7.0×11 topics
- Echocardiography3▲ 11×6 topics
- Prognostic Factors3▲ 6.3×8 topics
- Intensive Care Unit3▲ 22×2 topics
- Surgical Management3▲ 6.2×8 topics
- Cancer Survivorship3▲ 34×2 topics
- Idiopathic Pulmonary Fibrosis3▲ 55×1 topic
- TGF-ß3▲ 17×1 topic
- Genetic Susceptibility3▲ 25×4 topics
- Prognosis3▲ 7.4×6 topics
- Patient-Reported Outcomes2▲ 42×1 topic
- Psychosocial Interventions2▲ 42×1 topic
- Sedation2▲ 25×2 topics
- Treatment Guidelines2▲ 10×3 topics
- Endovascular Repair2▲ 26×2 topics
- Pain Management2▲ 9.4×5 topics
Which research topics does Seirei Mikatabara General Hospital publish most on?
By volume in 2022–2025: Palliative Care and End-of-Life Issues, Lung Cancer Diagnosis and Treatment, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Cancer survivorship and care.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 7 works
- 2 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
- 3 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 3 works
- 4 Cancer survivorship and care Oncology 2 works
- 5 Pleural and Pulmonary Diseases Pulmonary and Respiratory Medicine 2 works
- 6 Grief, Bereavement, and Mental Health Clinical Psychology 2 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 8 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 2 works
- 9 Pain Management and Opioid Use Anesthesiology and Pain Medicine 2 works
- 10 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Seirei Mikatabara General Hospital's research output changed?
Output in 2018–2022 was 21% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hamamatsu
- Hamamatsu University School of Medicine
- Suzuki (Japan)
- Hamamatsu Photonics (Japan)
- Seirei Hamamatsu General Hospital
- Hamamatsu University
- Yamaha (Japan)
- Hamamatsu Medical Center
- Shizuoka University of Art and Culture
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.